Market Overview

Research and Markets: Disease and Therapy Review: Alzheimer's Disease


Research and Markets ( has announced the addition of the "Disease and Therapy Review: Alzheimer's Disease" report to their offering.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.

The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Alzheimer Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the Alzheimer's and dementia market, as well as sales of leading drugs and therapies are provided.

Key Topics Covered:

I. Overview

II. Incidence And Prevalence

III. Diagnosis

IV. Treament

V. Dosing

VI. Treatment Costs

VII. Market Size

VIII. Comments

IX. References/Resources

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Drug Discovery

View Comments and Join the Discussion!